Despite President Trump's recent executive order to reschedule cannabis, experts warn that it will do little to shield users from potential prosecution. The Department of Justice has already rescinded Biden-era guidance that directed U.S. attorneys to refrain from pursuing simple cannabis possession cases. Montana's legal marijuana industry has reached a major milestone, with over $1 billion in sales since the state legalized adult-use cannabis four years ago. The data shows a dramatic shift in consumer habits, as adult-use sales have surged while medical marijuana purchases have plummeted. As the new year begins, the push for marijuana legalization is gaining steam across the country. From the East Coast to the West, states are eyeing opportunities to enact both recreational and medical cannabis laws, bolstered by a recent federal move to reschedule the drug. This study explored adolescent attitudes towards cannabis use and how they relate to attitudes towards alcohol use. The key findings indicate that adolescents view cannabis use as more acceptable than alcohol use, and that they often use cannabis to cope with stress or social anxiety. This study examined the relationship between monthly simultaneous cannabis and alcohol use and mental health outcomes in male and female college students. The key findings were that simultaneous use was associated with higher levels of depression, anxiety, and stress, and these associations differed by sex, with stronger links observed in female students. This study examined the day-level effects of cannabis and alcohol use on sleep quality and duration among middle-aged and older adults in the community. The key findings suggest that cannabis use alone had negligible effects on sleep, but co-use of cannabis and alcohol attenuated the negative effects of alcohol on sleep.

Visit The Cannabis Boomer Podcast homepage at https://www.cannabisboomer.com for in-depth interviews with leading cannabis researchers.

#CannabisResearch #MarijuanaLegalization #AdolescentSubstanceUse #AlcoholAndCannabisCoUse #SleepQuality #CannabisScience #THC #CBD #OlderAdults #BabyBoomers

Massachusetts Moves Forward with Cannabis Cafes and Equity Initiatives The Massachusetts Cannabis Control Commission is ushering in a new era for the state's cannabis industry. With the recent legalization of social consumption, the commission is paving the way for cannabis cafes and lounges, providing new opportunities for social equity applicants disproportionately impacted by the war on drugs. Commission Chair Shannon O'Brien explains that these new licenses will be exclusively available to those who have been personally, or whose family members have been, affected by the criminalization of cannabis. The focus is on promoting public health and safety, with stringent regulations around ventilation and coordination with local officials. However, O'Brien acknowledges that the social equity program has yet to see the level of success they had hoped for, citing barriers to accessing capital as a key challenge. Seniors Embrace Cannabis as Pot Stocks Await Reclassification The senior population in the United States is increasingly turning to cannabis, with a 46% surge in usage reported. This trend coincides with President Trump's recent executive order to reclassify marijuana, a move that could have significant implications for the burgeoning cannabis industry. As the baby boomer generation ages, many are seeking alternative remedies to manage various health conditions. The appeal of cannabis, with its potential therapeutic benefits from compounds like CBD and THC, has resonated with this demographic. Experts suggest that seniors are drawn to cannabis as a natural solution for pain management, anxiety, and sleep issues, among other ailments. Marijuana Consumption Expands Across Massachusetts In a groundbreaking move, the Massachusetts Cannabis Control Commission has unanimously approved the expansion of on-site marijuana consumption in the state. This new regulation allows non-cannabis businesses, such as yoga studios and movie theaters, to obtain licenses to host consumption areas for adults aged 21 and over. Commission Chair Shannon O'Brien expressed that residents have been "eagerly" waiting for this opportunity to socially consume marijuana, and the new licenses will offer economic opportunities for small businesses and entrepreneurs. Neurocognitive outcomes in adolescents with and without four weeks of cannabis abstinence: a randomized clinical trial using contingency management. This study examined the neurocognitive effects of cannabis abstinence in adolescents. The key findings showed that adolescents who abstained from cannabis for four weeks exhibited improved neurocognitive performance compared to those who continued using cannabis. The study also found that contingency management was an effective intervention to promote cannabis abstinence. Cannabidiol reduces oxycodone self-administration while preserving its analgesic efficacy in a rat model of neuropathic pain. This study investigated the effects of CBD on oxycodone self-administration and hyperanalgesia in an animal model of chronic neuropathic pain. The key findings are that CBD reduced oxycodone self-administration in both sham and neuropathic pain rats, while the antinociceptive effects of oxycodone were preserved in the neuropathic pain group. Increasing use of cannabis edibles in response to recreational cannabis legalization in the United States. This study evaluated the associations between recreational cannabis legalization in the United States and primary mode of cannabis use, including smoking, eating/drinking, and vaporizing/dabbing. The key findings showed that the use of cannabis edibles increased significantly after recreational cannabis legalization, while the use of smoking and vaporizing/dabbing remained relatively stable.

To hear in-depth interviews on these and other topics, go to The Cannabis Boomer Podcast homepage at https;//www.cannabisboomer.com

#CannabisBoomer #CannabisNews #CannabisResearch #CannabisLegalization #CannabisEquity #CannabisEdibles #OpioidCrisis #NeurocognitiveEffects #CannabisAbstinence #CannabisConsumption

The state of Michigan is gearing up for a potential shakeup in the cannabis industry as a looming ban on high-THC hemp products could have significant implications for consumers. Industry experts warn that the ban could lead to a potential shortage of these unregulated products, potentially driving up prices or forcing consumers to seek alternatives, which may include turning to the licensed dispensaries. In a major development for the state's medical cannabis program, Kentucky Governor Andy Beshear has announced the first licensed medical cannabis processor in the Commonwealth. This marks a significant milestone for the state's medical cannabis program, which has faced some delays in getting off the ground. Beshear expressed his desire to see the program accelerate. As the use of medical cannabis continues to grow, healthcare providers are playing a crucial role in guiding patients through the complexities of this emerging field. Dr. Wen emphasizes the importance of healthcare providers taking the time to understand each patient's unique needs and medical history, and then providing personalized recommendations based on the available scientific evidence. Kentucky lawmakers have introduced a bill that would allow voters to decide the fate of recreational cannabis in the state. If approved, the bill would allow individuals to possess up to an ounce of cannabis and grow up to five plants for personal use. The proposed legislation aims to address the injustices of cannabis prohibition. A study found that a history of cannabis smoking was associated with a higher likelihood of subjective cognitive complaints, and this association was stronger among women with a longer duration of cannabis use. Another study suggests that medical cannabis may be a viable treatment option for individuals with depression, potentially offering an alternative or adjunct to traditional pharmacological interventions. A study comprehensively assessed the influence of adolescent cannabis use onset on neurocognitive trajectories and the impact of recent THC and CBD exposure. The findings highlight the potential detrimental effects of adolescent cannabis use on neurocognitive development.

#CannabisResearch #MedicalCannabis #AdolescentCannabisUse #CognitiveFunction #Depression #KentuckyCannabis #MichiganCannabis #THC #CBD #BabyBoomers #OlderAdults

Cannabis Consumers Demand Equal Gun Rights After Rescheduling In a major victory for cannabis advocates, the federal government has reclassified marijuana from a Schedule One to a Schedule Three controlled substance. This move has prompted a prominent gun rights group to call for the restoration of firearm ownership rights for state-authorized cannabis consumers. Gun Owners of America, a leading pro-Second Amendment organization, is urging federal authorities to stop treating lawful cannabis users as "unlawful users of controlled substances" who are prohibited from possessing firearms. The group argues that with marijuana no longer classified as a dangerous, high-risk drug, there is no justification for denying gun rights to responsible cannabis consumers, particularly in states where the substance is legally regulated. Floridians Divided Over Proposed Cannabis Open-Container Law In a move that has sparked debate across the Sunshine State, a Florida lawmaker has introduced a bill that would ban the possession of open or ready-to-use cannabis products inside vehicles. The proposed legislation, known as the "Clear Minds, Safe Roads Act," aims to enhance road safety by mirroring the state's existing open-container laws for alcohol. Supporters of the bill argue that the measure is necessary to address the growing issue of impaired driving due to cannabis use, while critics are concerned about the potential impact on medical marijuana patients and the possibility of increased profiling. Cannabis involvement and mass shooting events in the United States from 1900 to 2019 This study examined the association between cannabis involvement and mass shootings in the United States from 1900 to 2019. The key findings indicate that a significant proportion of mass shooters had a history of cannabis use, and some had evidence of CBD or THC in their system at the time of the incident. However, the study has serious methodological flaws, as the authors do not show that shooters have a higher incidence of cannabis use than a demographically controlled population, and they do not acknowledge the length of time measurable cannabis can stay in the body long after use. Medical cannabis for chronic pain management: questions and answers between clinical and medico-legal issues This research article discusses the clinical and medico-legal aspects of using medical cannabis for chronic pain management. The key findings indicate that the efficacy of medical cannabis on pain reduction is statistically significant compared to placebo, with a mean reduction in the Numeric Rating Scale from baseline. While the incidence of serious adverse events was rare, medical cannabis may significantly increase AEs such as dizziness, tiredness, drowsiness, and nausea. Interactive associations of cannabis and alcohol outlet densities with assault injuries in California: a spatiotemporal analysis This study examined the impacts of recreational cannabis outlets on neighborhood-level assault injury rates in California and evaluated whether alcohol outlet density moderated these associations. The key findings were that the introduction of recreational cannabis outlets may have contributed to a small increase in nonfirearm assault injuries, but there was no association with firearm assault injuries. A hypothetical 20 percent reduction in alcohol outlet densities was associated with fewer firearm and nonfirearm assault injuries.

#Cannabis #GunRights #Florida #MassShootings #ChronicPain #AssaultInjuries #AlcoholOutlets #CannabisOutlets #THC #CBD #OlderAdults #BabyBoomers

On today's Cannabis Boomer's Journal of News and Reviews in Cannabis Science, Dr. Alex Terrazas PhD gives his take on the latest findings in cannabis research. Florida Moves to Restrict Medical Marijuana Use in Vehicles A new bill has been introduced in the Florida Senate that aims to crack down on the transportation of open cannabis products. The proposed legislation would make it illegal for both drivers and passengers to have open containers of medical marijuana, hemp, or THC-infused products in their vehicles. Patient advocates warn that it could create significant hardships for the state's nearly 1 million registered medical marijuana users. DEA Delays Cannabis Rescheduling Decision Despite Executive Order The Drug Enforcement Administration has confirmed that the process to reschedule cannabis remains in limbo, despite a recent executive order from President Trump directing the attorney general to complete the reform "in the most expeditious manner." The delay stands in contrast to the DEA's moves to increase production quotas for psychedelics like psilocybin and DMT. Delaware Decriminalizes Public Marijuana Smoking The state of Delaware has passed a bill that decriminalizes the public consumption of marijuana. Individuals caught smoking marijuana in public will face a civil fine of $100, rather than criminal charges. Supporters of the bill argue that this move will help address racial disparities in marijuana-related arrests and destigmatize the use of the drug. Real-world efficacy and safety of CBD in developmental and epileptic encephalopathies This study found that CBD was effective in reducing seizure frequency across various developmental and epileptic encephalopathies, including off-label indications, and was generally well-tolerated, with adverse events being mostly mild to moderate in severity. Rethinking Alzheimer's: Harnessing CBD to Modulate I D O and c GAS Pathways for Neuroinflammation Control This study investigated how CBD independently influences two key neuroinflammatory regulators in Alzheimer's disease. The findings support CBD as a potential monotherapy or adjunctive treatment for Alzheimer's Disease by targeting distinct neuroinflammatory pathways. CBD as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function This research article explores the potential of CBD as a therapeutic agent for Alzheimer's disease, focusing on its ability to mitigate disease pathology and enhance cognitive function. The key findings indicate that CBD exhibits neuroprotective effects, reduces neuroinflammation, and improves cognitive performance in Alzheimer's disease models. #CannabisBoomer

#THC #CBD #CannabisScience #MedicalMarijuana #Alzheimer'sDisease #Epilepsy #CBD #DEA #Rescheduling #PublicConsumption #Florida #Delaware #Research #Science #BabyBoomers #OlderAdults

Congress Clears Path for Marijuana Rescheduling, Preserves State Medical Cannabis Protections In a significant move, congressional leaders have dropped their attempt to block the rescheduling of marijuana, while maintaining crucial protections for state medical cannabis programs. This bipartisan agreement comes on the heels of President Trump's executive order directing the Justice Department to expedite the process of moving marijuana from Schedule I to Schedule III of the Controlled Substances Act. Nebraska Approves First Medical Cannabis Cultivator License Nebraska's long-awaited medical cannabis program is finally taking shape, as the state's Medical Cannabis Commission approved its first cultivator license this week. The move comes after voters overwhelmingly approved medical marijuana in the 2024 election, and signals progress in establishing a regulated supply chain for patients. Uncertain Future for Hemp Farming as Federal Regulations Loom The hemp industry is facing a potential crisis as a federal ban on hemp-derived THC products looms. After years of growth, the crop's future is now in jeopardy, with the vast majority of hemp-based products set to become illegal in a matter of months. Clinical Approach to Acute Recreational Drug Intoxication in the Emergency Setting: A Practical Guide Based on Swiss Experience This research article summarizes the current evidence and recommendations for the clinical management of acute recreational drug intoxication in emergency departments. Cannabis use and psychotic-like experiences in the This study examined the association between cannabis use and psychotic-like experiences in a contemporary United States sample, adjusting for other risk factors.

#CannabisNews #CannabisResearch #MedicalCannabis #HempIndustry #DrugIntoxication #PsychoticExperiences #THC #CBD #BabyBoomers #OlderAdults

Tribal Cannabis Deals Soar in 2026 2026 has been a landmark year for tribal cannabis, with the Bois Forte Band and Red Lake Nation striking major agreements that are reshaping the industry. These deals cap off a year of unprecedented growth and opportunity for Native American communities in the cannabis space. Florida Marijuana Proposal Faces Legal Challenges In a high-stakes battle over the future of recreational marijuana in the Sunshine State, Florida Attorney General James Uthmeier and two major business groups have urged the state's Supreme Court to reject a proposed constitutional amendment that would legalize the use of cannabis for adults aged 21 and older. Marijuana and School Funding: The Contentious Issues Ahead The 20 26 legislative session in Indiana is shaping up to be a battleground for two highly contentious issues: the legalization of marijuana and the ongoing debate over school funding. As lawmakers gather at the Statehouse, these topics are expected to dominate the agenda and spark intense discussions. Medical Marijuana and Treatment Personalization: The Role of Genetics and Epigenetics in Response to THC and CBD This research examines the role of genetic and epigenetic factors in personalized medical marijuana therapy. The key findings indicate that variants in phase I and II drug-metabolizing enzymes, as well as epigenetic markers, can influence an individual's response to THC and CBD. Cognitive Difficulty Concentrating, Remembering, or Making Decisions According to Chronic Medical Conditions and Cannabis Use Among US Adults This study explored the independent and co-occurring effects of cannabis use and chronic diseases on cognitive difficulties among US adults. The key findings indicate that both cannabis use and chronic diseases were associated with increased cognitive difficulties, and the combination of the two factors had an additive effect. Changes in sleep quality during the 12 months following medical cannabis initiation This study examined the long-term impact of medical cannabis use on subjective sleep quality among adults in Pennsylvania over a 12-month period. The key findings were that sleep quality improved significantly in the first 3 months of medical cannabis use and remained improved throughout the 12-month follow-up period.

#CannabisBoomer #CannabisNews #CannabisResearch #MedicalCannabis #TribeCannabis #FloridalegalizationChallenges #IndianaMarijuanaLegalization #SchoolFunding #Pharmacogenomics #Epigenetics #CognitiveFunction #SleepQuality

On the federal government's recent announcement to reschedule cannabis, the move could have far-reaching implications. It will effectively decriminalize the substance at the federal level, allowing states more autonomy in determining their own cannabis laws. This is expected to facilitate more robust scientific research into the potential medical benefits of compounds like CBD and THC.

Tyson Praises Trump's Cannabis Reform, Predicts Five Hundred Thousand New Jobs. Boxing legend Mike Tyson has enthusiastically endorsed President Trump's recent executive order reclassifying cannabis as a less dangerous drug, believing it will pave the way for significant job growth.

A review of recent evidence for the effectiveness of medical cannabis indicates that while public interest and research output have surged, the measured clinical benefits are generally modest, variable, and limited by research challenges. Future progress will depend on standardized products, rigorous trials, and clinician education.

A study on healthcare professionals' perspectives on medicinal cannabis in Malta found variable attitudes, with some expressing concerns about its clinical integration despite established legislation. This highlights the need to address knowledge gaps to facilitate its effective and safe use.

A review of the therapeutic use of cannabis and cannabinoids found that their use is approved for certain conditions, but the evidence for their use in chronic non-cancer pain, insomnia, and other disorders is inconclusive. Clinicians must carefully evaluate the potential benefits and risks.

#CannabisResearch #MedicalCannabis #CannabisLegalization #CannabisPolicy #CannabisScience #CannabisBoomer #CannabisNews #CannabisTherapeutics #CannabisRegulation #CannabisHealthcare

https://player.captivate.fm/episode/f3a78c33-ea66-4bae-a4a8-2b7e7c851cac/

Trump Expected to Ease Federal Marijuana Restrictions The cannabis industry is buzzing with anticipation as President Trump prepares to sign an executive order that could significantly impact the legal landscape for marijuana. The potential reclassification could pave the way for increased research, development, and commercialization of both THC and CBD-based products, providing a much-needed boost to an industry that has long operated in a legal gray area.

Marijuana in Your Car:

Understanding Arizona's Laws Arizona legalized marijuana in 2020, but with that came a new set of rules and regulations. There are strict limits on the amount of THC and CBD you can possess at any given time, and the law also regulates how you can transport it. Failure to follow these guidelines could lead to charges related to the transportation of a controlled substance. Plummeting Cannabis Cultivation Permits Reshape the Industry The U.S. cannabis industry is undergoing a significant shift, as the number of active cultivation permits has dropped by a staggering 24% since 2023. Industry experts attribute this contraction to a complex interplay of factors, including oversaturation, regulatory changes, and evolving consumer preferences.

Cannabis social equity initiatives among US states with legal non-medical cannabis retail: A review and recommendations This study described state social equity initiatives related to equitable industry entrepreneurship opportunities, community reinvestment, and criminal justice reform. The findings suggest that these social equity initiatives may help address historical inequities and promote more equitable participation in the cannabis industry. Mothers Marketing to Mothers: An Exploration of Cannabis Use and Constructions of Motherhood on Instagram and Blog Posts This study explored the online movement of "Cannamom culture", which promotes the acceptance of cannabis use among mothers. The findings highlight the need for healthcare providers and policymakers to understand the online narratives around cannabis use and motherhood, and to develop appropriate interventions and policies. Pictorial warning labels reduce sharing intentions, blunt self-relevance processes elicited by social media posts promoting cannabis edibles This study examined the effects of warning labels on individuals' intentions to share social media posts promoting cannabis edibles and the underlying neural mechanisms. The findings suggest that warning labels may discourage sharing by negatively influencing perceptions of self-relevance.

#CannabisNews #CannabisResearch #SocialEquity #Cannamoms #WarningLabels #CannabisIndustry #ArizonaCannabisLaws #FederalMarijuanaRestrictions

On Trump's Cannabis Rescheduling: A Surprising Shift in the War on Drugs

The political landscape around cannabis reform in the United States is undergoing a dramatic shift, and it's coming from an unexpected source - a Republican president. Donald Trump has confirmed that he is "very strongly" considering rescheduling cannabis from its current Schedule I classification, where it sits alongside heroin, to Schedule III, a move that could revolutionize federal drug policy. This decision represents a significant departure from the GOP's traditional "tough on drugs" stance, but Trump's reasoning appears to be more about the potential economic benefits than social justice concerns.

Navigating Virginia's Cannabis Legalization: Opportunities and Challenges Ahead

As Virginia prepares to legalize the retail sale of cannabis, the implications of this landmark legislation are far-reaching. The absence of an "opt-out" provision is expected to have the most significant effect on the conservative-leaning regions of Southwest and Southside Virginia, where the proximity to state borders could make these areas prime locations for cannabis businesses. The legislation also introduces a radius rule, limiting the proximity of cannabis stores to one another, which could lead to contentious decisions regarding license allocation. The newly empowered Cannabis Control Authority will be responsible for navigating these complex issues, raising questions about the expertise and priorities that will shape the industry's development.

North Providence Limits Cannabis Stores to Industrial Zones

North Providence is taking steps to restrict the locations of future cannabis stores in the town. The Planning Board has recommended that the Town Council amend the zoning ordinance to only allow cannabis retailers in the town's limited manufacturing general zones, which are primarily industrial areas away from residential neighborhoods. The goal is to protect residents from the potential impacts of cannabis businesses, such as chemicals, noise, and machinery. The move comes after North Providence residents voted in 2022 to allow recreational cannabis sales in the town, and the Planning Board's recommendation aims to strike a balance between honoring the will of the voters and minimizing the potential disruption to the community.

The History and Use of Medical Cannabis by Weber in Journal of Christian Nursing

This article explores the historical trajectory of medical cannabis from early therapeutic uses to integration into Western medicine, subsequent prohibition, and cautious resurgence. Archaeological and historical evidence indicate that cannabis has been used for medicinal purposes for almost 5,000 years. The article provides a comprehensive view of cannabis' evolving role in health and healing across cultures and centuries, and discusses the implications for Christian healthcare providers regarding the use of medical cannabis.

Patients' Perspectives and Experiences of Cannabis to Manage Symptoms of Chronic Kidney Disease: An In-Depth Interview Study by Walker and others in Hemodialysis International

This study explored the experiences of people with kidney failure using cannabis to manage their symptoms. The key findings were that participants reported using CBD and THC to alleviate symptoms such as pain, nausea, and insomnia, and that they perceived cannabis as more effective and safer than conventional medications. However, they also faced barriers to accessing and using cannabis. The findings suggest that cannabis may be a viable treatment option for managing the symptoms of kidney disease, but further research is needed to understand its efficacy and safety in this population.

#cannabis #cannabisresearch #cannabislegalization #medicalcannabis #chronickidneydisease #trumpcannabis #virginiacannabis #northprovidencecannabis